Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
2.59%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth2.59%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
59.99%
80%
—
—
Never
—
5 Years
Score—
Net Growth59.99%
Net Trend80%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Adial Pharmaceuticals Inc fundamental performance
Across Adial Pharmaceuticals Inc's full reported history, from 2018 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 11M to -$ 7M. Revenue increased in 0% of the years measured; net income in 63%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.31 | — |
1 Year2025-08-12 | $ 9.88 | -56.35% |
5 Years2021-08-12 | $ 1.94K | -99.78% |
All Time2018-07-30 | $ 2.5K | -99.83% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-07-30 |
|---|---|---|---|---|
| Price | $ 4.31 | $ 9.88 | $ 1.94K | $ 2.5K |
| Return | — | -56.35% | -99.78% | -99.83% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 7M | $ 4M |
| 2025 | $ 0.00 | -$ 7M | $ 5M |
| 2024 | $ 0.00 | -$ 13M | $ 3M |
| 2023 | $ 0.00 | -$ 7M | $ 2M |
| 2022 | $ 0.00 | -$ 12M | $ 4M |
| 2021 | $ 0.00 | -$ 19M | $ 6M |
| 2020 | $ 0.00 | -$ 10M | $ 4M |
| 2019 | $ 0.00 | -$ 8M | $ 6M |
| IPO2018 | $ 0.00 | -$ 11M | $ 3M |
Explore beyond ADIL
You're looking at Adial Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
